Immune Clustering Reveals Molecularly Distinct Subtypes of Lung Adenocarcinoma.

(iii) Highly significant differences were observed in the expression levels of some of the targets of immune checkpoint inhibitors (e.g., PD-L1, which differed between sub1 and sub0) ( Figure 5 ).

also in 132,142 other papers